DSS, Inc. DSS has filed for the distribution of a special stock dividend to DSS Inc. shareholders of record on June 30 for distribution on July 14.
DSS shareholders of record as of 4:00 p.m. ET on June 30, 2021 (the “record date”) will receive four (4) shares of Impact Biomedical, Inc. for every one (1) share of DSS.
Impact BioMedical, Inc. is a wholly owned subsidiary of DSS. Impact BioMedical leverages its scientific expertise and intellectual property rights to provide solutions that have been plaguing the biomedical field for decades.
DSS is a multinational company operating businesses within nine divisions: Product Packaging, Biotechnology, Direct Marketing, Commercial Lending, Securities and Investment Management, Alternative Trading, Digital Transformation, Secure Living, and Alternative Energy.
Image sourced from Shutterstock
This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.